TCL Archive Breast Cancer Low Fat Investigators to Seek R01 Funds for New Compliance, Biochemical Studies April 25, 1986
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA October 15, 1982
